Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
78.7 EUR | +0.19% | -0.88% | -0.51% |
04-02 | Bernstein starts AstraZeneca at 'outperform' | AN |
02-22 | Transcript : Kerry Group plc Presents at 2024 Consumer Analyst Group of New York Conference, Feb-22-2024 10:00 AM |
Sales 2024 * | 7.99B 8.57B 11.7B | Sales 2025 * | 8.49B 9.11B 12.42B | Capitalization | 13.91B 14.92B 20.35B |
---|---|---|---|---|---|
Net income 2024 * | 720M 772M 1.05B | Net income 2025 * | 827M 887M 1.21B | EV / Sales 2024 * | 1.93 x |
Net Debt 2024 * | 1.55B 1.67B 2.27B | Net Debt 2025 * | 1.08B 1.15B 1.57B | EV / Sales 2025 * | 1.76 x |
P/E ratio 2024 * |
19.2
x | P/E ratio 2025 * |
16.5
x | Employees | 21,000 |
Yield 2024 * |
1.58% | Yield 2025 * |
1.74% | Free-Float | 88.56% |
Latest transcript on Kerry Group plc
1 day | +0.19% | ||
1 week | -0.88% | ||
Current month | -2.30% | ||
1 month | -2.30% | ||
3 months | -2.84% | ||
6 months | +8.55% | ||
Current year | -0.51% |
Managers | Title | Age | Since |
---|---|---|---|
Edmond Scanlon
CEO | Chief Executive Officer | 50 | 17-01-31 |
Director of Finance/CFO | 53 | 88-12-31 | |
Gerry Behan
PSD | President | 59 | 08-05-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mike Kerr
BRD | Director/Board Member | 64 | 21-05-02 |
Director/Board Member | 64 | 18-05-07 | |
Director/Board Member | 69 | 10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 78.7 | +0.19% | 68,593 |
24-04-25 | 78.55 | -4.32% | 76,896 |
24-04-24 | 82.1 | +2.50% | 116,083 |
24-04-23 | 80.1 | -1.72% | 154,428 |
24-04-22 | 81.5 | +2.64% | 84,073 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.93% | 266B | |
-2.51% | 94.98B | |
+3.19% | 46.39B | |
+8.74% | 39.99B | |
-0.65% | 39.95B | |
-0.15% | 38.02B | |
-16.78% | 30.16B | |
-6.04% | 28.72B | |
+11.32% | 24.54B |
- Stock Market
- Equities
- KRZ Stock
- KYGA Stock